Cancer biomarkers: Emerging trends and clinical implications for personalized treatment

被引：89
|
作者：
Passaro, Antonio [1 ]
Al Bakir, Maise [2 ,3 ]
Hamilton, Emily G. [4 ]
Diehn, Maximilian [4 ]
Andre, Fabrice [5 ,6 ]
Roy-Chowdhuri, Sinchita
Mountzios, Giannis [7 ]
Wistuba, Ignacio I. [8 ]
Swanton, Charles [2 ,3 ,9 ]
Peters, Solange [10 ]
机构：
[1] European Inst Oncol IRCCS, Div Thorac Oncol, Milan, Italy
[2] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England
[3] UCL, Canc Res UK Lung Canc Ctr Excellence, Canc Inst, London, England
[4] Stanford Univ, Stanford Canc Inst, Sch Med, Dept Radiat Oncol, Stanford, CA USA
[5] Paris Saclay Univ, Gustave Roussy Canc Ctr, Villejuif, France
[6] Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol & Translat Mol Pathol, Houston, TX USA
[7] Henry Dunant Hosp Ctr, Dept Med Oncol 4, Athens, Greece
[8] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77054 USA
[9] Univ Coll London Hosp, Dept Oncol, London, England
[10] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland
来源：
CELL | 2024年 / 187卷 / 07期
关键词：
CELL LUNG-CANCER; CIRCULATING-TUMOR DNA; IMMUNE CHECKPOINT INHIBITORS; MOLECULAR RESIDUAL DISEASE; EXOME ANALYSIS REVEALS; KRAS MUTATION STATUS; PD-1; BLOCKADE; BREAST-CANCER; T-CELLS; MICROSATELLITE INSTABILITY;
D O I：
10.1016/j.cell.2024.02.041
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The integration of cancer biomarkers into oncology has revolutionized cancer treatment, yielding remarkable advancements in cancer therapeutics and the prognosis of cancer patients. The development of personalized medicine represents a turning point and a new paradigm in cancer management, as biomarkers enable oncologists to tailor treatments based on the unique molecular profile of each patient's tumor. In this review, we discuss the scientific milestones of cancer biomarkers and explore future possibilities to improve the management of patients with solid tumors. This progress is primarily attributed to the biological characterization of cancers, advancements in testing methodologies, elucidation of the immune microenvironment, and the ability to profile circulating tumor fractions. Integrating these insights promises to continually advance the precision oncology field, fostering better patient outcomes.
引用
收藏
页码：1617 / 1635
页数：19
相关论文
共 50 条
  • [1] Emerging Biomarkers for Pancreatic Neoplasms: Implications for Personalized Medicine
    Rivera, Laura
    JOURNAL OF THE PANCREAS, 2024, 25 (04):
  • [2] Emerging Biomarkers in Personalized Therapy of Lung Cancer
    Cagle, Philip T.
    Raparia, Kirtee
    Portier, Bryce P.
    LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : 25 - 36
  • [3] Emerging Biomarkers in the Era of Personalized Cancer Medicine
    Ricciuti, Biagio
    Leonardi, Giulia C.
    Brambilla, Marta
    DISEASE MARKERS, 2019, 2019
  • [4] Novel technologies and emerging biomarkers for personalized cancer immunotherapy
    Yuan, Jianda
    Hegde, Priti S.
    Clynes, Raphael
    Foukas, Periklis G.
    Harari, Alexandre
    Kleen, Thomas O.
    Kvistborg, Pia
    Maccalli, Cristina
    Maecker, Holden T.
    Page, David B.
    Robins, Harlan
    Song, Wenru
    Stack, Edward C.
    Wang, Ena
    Whiteside, Theresa L.
    Zhao, Yingdong
    Zwierzina, Heinz
    Butterfield, Lisa H.
    Fox, Bernard A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [5] Colon Cancer Biomarkers: Implications for Personalized Medicine
    Pritzker, Kenneth P. H.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04):
  • [6] Pharmacogenomic biomarkers for personalized cancer treatment
    Rodriguez-Antona, C.
    Taron, M.
    JOURNAL OF INTERNAL MEDICINE, 2015, 277 (02) : 201 - 217
  • [7] Emerging biomarkers for precision diagnosis and personalized treatment of cystic fibrosis
    Tamer A. Addissouky
    Ibrahim El Tantawy El Sayed
    Majeed M. A. Ali
    Yuliang Wang
    Journal of Rare Diseases, 3 (1):
  • [8] Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer
    Sinicrope, Frank A.
    Okamoto, Koichi
    Kasi, Pashtoon M.
    Kawakami, Hisato
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (05) : 651 - 658
  • [9] Emerging trends in the treatment of rectal cancer
    Minsky, Bruce D.
    ACTA ONCOLOGICA, 2019, 58 (10) : 1343 - 1351
  • [10] Emerging Role of microRNAs in Prostate Cancer: Implications for Personalized Medicine
    Gandellini, Paolo
    Folini, Marco
    Zaffaroni, Nadia
    DISCOVERY MEDICINE, 2010, 9 (46) : 212 - 218
12345